Given that long-term survival of untreated stage 1 non-small cell lung cancer (NSCLC) is virtually nil, and that five-year survival of surgically resected stage I NSCLC is as high as 80 per cent, early surgical resection and ablative therapy is indicated, according to investigators at the University of California at San Francisco.

Yesterday, Roche chief executive Franz Humer said the drug is on course for a US launch for the treatment of non-small cell cancer in the second half of 2007.

Disease is deadlier than some of the diseases that have their own ribbons but it get the least support for research.

Joel Davy, the subject of a series of heartfelt, personal columns in the North County Times, died Saturday morning after a long fight with lung cancer, a time in which her strength and courage inspired everyone around her.

CTRC is only one of three sites in the Unites States, and the only one in Texas, to be enrolling patients for this new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung.

Most Danish cancer patients die within six months of the disease being detected, and most of those deaths are from lung cancer.

Tammy Faye Messner, who as Tammy Faye Bakker helped her husband, Jim, build a multimillion-dollar evangelism empire and then watched it collapse in disgrace, has died. She was 65.Messner had battled colon cancer since 1996 that more recently spread to her lungs. She died peacefully Friday at her home near Kansas City, Mo., said Joe Spotts, her manager and booking agent.

Radiation shaped to duplicate the dimensions of early-stage lung cancers are a good alternative to surgery for some patients, say New York researchers.

So called “conformal” radiation therapy uses information from CT and MRI scans to “sculpt” a radiation beam to the exact dimensions of a tumor.

The appearance of a rash in cancer patients treated with erlotinib (Tarceva®) is strongly associated with longer survival, according to researchers from the drug’s developer, OSI Pharmaceuticals, Inc.

Certain blood types appear to boost the risk of tobacco-linked lung cancer according to a new study.